$CCAP

Crescent Capital BDC, Inc.

Insider trades
0
1
0

No SEC Form 4 filings for $CCAP in the last 30 days.

See all $CCAP insider activity →
Med

Crescent Capital BDC, Inc. (CCAP): Results of Operations and Financial Condition

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ccap-ex99_1.htm EX-99.1 EX-99.1 Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results; Declares a Third Quarter Base Dividend of $0.34 Per Share LOS ANGELES, August 10, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) toda

Name Change Completed for C Capital’s Swiss Listed Entity, Ticker Symbol CCAP Goes Live

Youngtimers AG, listed on the Swiss Stock Exchange (YTME), said its renaming to C Capital Holdings AG was published in the Commercial Registry. Shares are expected to start trading today under the new name and ticker CCAP. The company said shareholder rights, asset ownership, and agreements are unchanged, with only the holding-parent brand updated.

Crescent Capital BDC, Inc. (CCAP): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 8-K false 0001633336 0001633336 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 18,

CCAP sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning CCAP (Crescent Capital BDC, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent CCAP coverage spans financial news, earnings and corporate actions.

What's driving CCAP

  • The filing provides fresh earnings and capital-return details (NAV level and dividend amounts) that can drive near-term income and NAV-focused positioning.

    SEC EDGAR 8-K · Aug 10, 2026

  • Ticker/name change should be a near-term liquidity/identifier event; fundamentals are stated as unchanged.

    portal.sina.com.hk · Jun 26, 2026

  • The 8-K discloses a larger revolver commitment and higher maximum principal, which can improve liquidity and funding flexibility for CCAP’s lending activities.

    SEC EDGAR 8-K · Jun 24, 2026

  • The CEO's purchase of 5,000 shares at $11.19 suggests positive insider sentiment, potentially indicating confidence in Crescent Capital BDC's near-term prospects.

    Stock Titan · May 22, 2026

  • Insider purchase of $958,485 worth of common stock by a director at Crescent Capital BDC signals possible undervaluation or positive outlook, but the stock's proximity to its 52-week low warrants cautious interpretation.

    Investing.com · May 21, 2026

alphai scores every news story that mentions CCAP with an AI model for sentiment and relevance, and aggregates insider trades from Crescent Capital BDC, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CCAP

Score
$CCAPMed

Crescent Capital BDC, Inc. (CCAP): Results of Operations and Financial Condition

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ccap-ex99_1.htm EX-99.1 EX-99.1 Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results; Declares a Third Quarter Base Dividend of $0.34 Per Share LOS ANGELES, August 10, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) toda

$CCAPLow

Crescent Capital BDC, Inc. (CCAP): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 8-K false 0001633336 0001633336 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 18,

$CCAPMed

Crescent Capital BDC (CCAP) CEO buys 5,000 shares in open market

Crescent Capital BDC, Inc. CEO Jason Breaux recently purchased 5,000 shares of company common stock in an open-market transaction on May 20, 2026, at a price of $11.19 per share. This acquisition increased his direct holdings to 52,636 shares, signaling positive sentiment towards the company. The transaction was detailed in a Form 4 SEC filing, which also provides further insights into the purchase.

$CCAPMed

Crescent Capital BDC director buys $958,485 of common stock

A director at Crescent Capital BDC, Steven F. Strandberg, recently purchased 85,000 shares of the company's common stock for $958,485. This insider buying occurred while the stock was trading near its 52-week low following a significant decline. The article also provides recent analyst ratings and corporate governance updates for Crescent Capital BDC.

$CCAPMed

Dividends and fee cuts in Crescent Capital BDC (NASDAQ: CCAP) Q1 2026 update

Crescent Capital BDC (CCAP) announced its Q1 2026 results, reporting a net investment income of $0.42 per share but a net loss of $0.42 per share due to investment losses. The company also declared a regular dividend of $0.34 per share for Q2 2026 and special dividends totaling $0.09 per share, payable in three installments. Furthermore, CCAP reduced its base management and incentive fees to better align with shareholder interests.

10 Best BDC Stocks to Buy Right Now

This article lists the top 10 best BDC (Business Development Company) stocks to buy, highlighting Crescent Capital BDC, Inc. (NASDAQ: CCAP) as one of them. It details Crescent Capital's Q4 2025 earnings, analyst recommendations, and management's strategic plans for improving consistent earnings and shareholder returns. The company focuses on lending to middle-market businesses to maximize shareholder returns through income and capital appreciation.

Crescent Capital BDC: This 13%+ Yielding Bargain Remains A Buy (NASDAQ:CCAP)

Crescent Capital BDC, Inc. (CCAP) offers a 13.4% dividend yield and trades at a significant discount to its net asset value. Despite potential dividend adjustments due to lower SOFR, the company's strong fundamentals, including robust dividend coverage and conservative portfolio LTV, suggest it remains a compelling investment. The article positions CCAP as a high-return, medium-risk opportunity with upside potential as market sentiment improves.

$FCRXMed

Crescent Capital BDC, Inc. (NASDAQ:CCAP) to Issue Quarterly Dividend of $0.42

Crescent Capital BDC, Inc. (NASDAQ:CCAP) has declared a quarterly dividend of $0.42 per share, payable on April 15th to shareholders of record on March 31st, implying an annual yield of approximately 12.8%. The company announced earnings per share of $0.45, surpassing analyst estimates, and reported strong revenue of $40.8 million. Despite a high dividend payout ratio of 97.7%, the dividend is currently covered by earnings, though its sustainability could be challenged if profits decline.

Crescent Capital BDC, Inc. Schedules Earnings Release and

Crescent Capital BDC, Inc. (NASDAQ: CCAP) announced it will release its fourth quarter and fiscal year-end 2025 financial results on Wednesday, February 18, 2026, after market close. The company will host a webcast and conference call on Thursday, February 19, 2026, at 12:00 p.m. Eastern Time to discuss these results. Interested parties can access the call via Crescent BDC's investor relations website or by dialing in using the provided conference ID.

Related tickers